Anna Sophia McKenney

Anna Sophia McKenney

Auto-generated profile, based on publicly available information

Anna Sophia McKenney

From the Department of Radiology, Division of Interventional Radiology, NewYork-Presbyterian Hospital/Weill Cornell Medicine, 525 E 68th St, P520, New York, NY 10065 (A.S.M.); and Department of Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (E.S.A., K.Z., E.Z., S.B.S., C.T.S., V.S.S.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2022 in Advances in Radiation Oncology
Verified
Journal Article
Open access
AMAnna Sophia McKenney
Anna Sophia McKenney
EWEmily Weg
Emily Weg
TBTejus A. Bale
Tejus A. Bale
AWAaron T. Wild
Aaron T. Wild
HUHyemin Um
Hyemin Um
HVHarini Veeraraghavan
Harini Veeraraghavan
Pseudoprogression mimicking recurrent glioblastoma remains a diagnostic challenge that may adversely confound or delay appropriate treatment or clinical trial enrollment. We sought to build a radiomic classifier to predict pseudoprogression in patients with primary isocitrate dehydrogenase wild type glioblastoma. We retrospectively examined a training cohort of 74 patients with isocitrate dehydrogenase wild type glioblastomas with brain magnetic resonance imaging including dynamic contrast enhanced T1 perfusion before resection of an enhancing lesion indeterminate for recurrent tumor or pseudoprogression. A recursive feature elimination random forest classifier was built using nested cross-validation without and with O6-methylguanine-DNA methyltransferase status to predict pseudoprogression. A classifier constructed with cross-validation on the training cohort achieved an area under the receiver operating curve of 81% for predicting pseudoprogression. This was further improved to 89% with the addition of O6-methylguanine-DNA methyltransferase status into the classifier. Our results suggest that radiomic analysis of contrast T1-weighted images and magnetic resonance imaging perfusion images can assist the prompt diagnosis of pseudoprogression. Validation on external and independent data sets is necessary to verify these advanced analyses, which can be performed on routinely acquired clinical images and may help inform clinical treatment decisions.

1 September 2021 in RadioGraphics
Verified
Journal Article
Closed access
AMAnna Sophia McKenney
Anna Sophia McKenney
TGTushar Garg
Tushar Garg
EKEsther Kim
Esther Kim
AKAndrew Kesselman
Andrew Kesselman

1 October 2022 in RadioGraphics
Verified
Journal Article
Closed access
VTValery L. Turner
Valery L. Turner
CKCiléin Kearns
Ciléin Kearns
KWKapil Wattamwar
Kapil Wattamwar
AMAnna Sophia McKenney
Anna Sophia McKenney

1 November 2023 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
MSMohamed M. Soliman
Mohamed M. Soliman
TKTae-Hyung Kim
Tae-Hyung Kim
MCMonica Cheng
Monica Cheng
AMAnna Sophia McKenney
Anna Sophia McKenney
MFMohammad-Kasim Fassia
Mohammad-Kasim Fassia
SWSungmin Woo
Sungmin Woo

1 September 2021 in RadioGraphics
Verified
Journal Article
Closed access
AKAditya Khurana
Aditya Khurana
CKCiléin Kearns
Ciléin Kearns
AMAnna Sophia McKenney
Anna Sophia McKenney
AGAhmed M. Gabr
Ahmed M. Gabr

1 December 2020 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
DTDennis Toy
Dennis Toy
SMSyed S. Mahmood
Syed S. Mahmood
JRJessica Rotman
Jessica Rotman
LGLauren K. Groner
Lauren K. Groner
SWStacey Verzosa Weisman
Stacey Verzosa Weisman
QTQuynh A. Truong
Quynh A. Truong
Background Coronavirus disease 2019 (COVID-19) affects vulnerable populations (VP) adversely. Purpose To evaluate overall imaging utilization in vulnerable subgroups (elderly, racial/ethnic minorit...